Ingrid Aune Bergstrøm - NTNU

Research

COSENSE-1 clinical trial

Phase II clinical trial for patients with metastatic colorectal cancer, where we choose between two chemotherapy regimens based on drug screening on patient-derived tumouroids (sometimes called tumour organoids or living biopsies). NTNU/Sintef/St. Olavs h

Publications

Moderate and severe traumatic brain injury: abbreviated injury scale scoring and coding of traumatic axonal injury from early MRI

Large prospective study of patients with moderate and severe traumatic brain injury (TBI) examined with early magnetic resonance imaging (MRI).

Continuous imaging to evaluate growth and drug responses of patient-derived colorectal tumouroids

Method for non-destructive, continuous image-based analysis of colorectal tumouroid growth and shape, under chemotherapeutic perturbations.